Home › Type 2 Diabetes › NCT05570734
Latinos Understanding the Need for Adherence in Diabetes Using E-Health
Latinos Understanding the Need for Adherence in Diabetes Using Care Coordination, Integrated Medical and Behavioral Care and E-Health
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Self identify as Hispanic/Latino ethnicity of any race 2. Registered patient of federally qualified health center 3. 18 years of age or older 4. Type 2 diabetes with hemoglobin A1C (HbA1c) \>7.5% in past 90 days 5. Approval from primary care provider 6. Not currently enrolled/participating in any other diabetes intervention program(s) Exclusion Criteria: 1. Actively being treated for cancer or Parkinson's Disease 2. Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum) 3. Have plans to move out of the area in the next 12 months 4. Have other existing mental or physical health problems so severe as to prohibit informed consent and participation 5. Have severe diabetes complications (e.g., renal disease, or on dialysis)
About the study
Latinos Understanding the Need for Adherence in Diabetes using Care Coordination, Integrated Medical and Behavioral Care and E-Health (LUNA-E) is a randomized controlled trial (RCT) that will test the effectiveness a patient-centered, team-based, primary care intervention with E-Health enhancements in improving glycemic control (primary outcome, hemoglobin A1C level) and psychological distress (secondary outcome; depression, anxiety symptoms).
What is being tested
- LUNA Care Coordination (behavioral)
- LUNA Behavioral Health (behavioral)
- Health Education Videos (behavioral)
- Virtual Integrated Visits (behavioral)
Sponsor: San Diego State University · Participants: 400 · Started: Feb 27, 2023
Contact the study team
- Program Manager · Phone: 619-594-8060
Official record on ClinicalTrials.gov — NCT05570734
Locations in the U.S.
| California | South Bay Latino Research Center, Chula Vista |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.